Sorsix was a silver supporter of the 2nd Australasian International Breast Congress (AIBC), held 8–10 October 2026 at the Brisbane Convention & Exhibition Centre.
Across three days, the team discussed how Pinga® Screening connects the breast care pathway. Conversations with clinicians and service teams kept returning to three challenges: fragmented care, bringing AI into clinical workflows and the limitations of legacy systems.
Care is still fragmented
The first was fragmentation. A participant’s breast pathway runs from screening invitation through imaging, assessment, multidisciplinary review, treatment and follow-up.
Each step often sits with a different team and a different system, and every handover can introduce delays or leave information behind. For clinicians, this can make it difficult to see the full picture as care moves between services.
Pinga® Screening connects the whole pathway on one shared participant record, so every clinician can see where a participant is and what needs to happen next.
Bringing AI into everyday clinical workflows
There is growing evidence that AI-supported mammography reading can help radiologists detect cancers that might otherwise be missed. The question clinicians asked at AIBC was how to adopt these tools safely inside their existing screening and assessment workflows.
Pinga® Screening provides the infrastructure to bring AI tools into reading and assessment workflows, while radiologists retain responsibility for clinical decisions. This allows services to incorporate AI support into the pathway their teams already work within.
Working beyond the limits of legacy systems
Many health services want to use AI and modern workflows but face integration barriers because their systems were built before these technologies existed.
Pinga® works as an orchestration layer above existing systems and connects through FHIR and HL7. Services can adopt new technology without replacing the systems their clinicians already depend on.
For the Sorsix team, AIBC reinforced the importance of connecting people, information and technology across the whole breast care pathway. We appreciate the clinicians and service teams who shared their experiences and helped ground these discussions in the realities of delivering care.
